SCHEMBL7797498

SCHEMBL7797498

N[C@@H](CC(=O)c1cccc(F)c1)C(=O)O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 3/20 0.61
PARP1 P09874 1/20 0.51
CES2 O00748 2/20 0.50
CES1 P23141 2/20 0.50
KDM4E B2RXH2 2/20 0.48
HIF1A Q16665 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
SLC1A1 P43005 2/20 0.47
MEN1 O00255 2/20 0.47
NPC1 O15118 2/20 0.47
TSHR P16473 2/20 0.47
KMT2A Q03164 2/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
ALOX12 P18054 1/20 0.47
HTT P42858 1/20 0.47
HDAC1 Q13547 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
CTNNB1 P35222 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7797488 1.00 KMO (0.61) KMOPARP1CES2CES1KDM4E
SCHEMBL7797494 1.00 KMO (0.61) KMOPARP1CES2CES1KDM4E
Hydrochloric Acid SCHEMBL27450879 0.98 KMO (0.59) KMOPARP1CES2CES1KDM4E
Hydrochloric Acid SCHEMBL27450880 0.98 KMO (0.59) KMOPARP1CES2CES1KDM4E
SCHEMBL9064575 0.82 KMO (0.62) KMOPARP1KDM4EHIF1ATDP1
SCHEMBL727304 0.82 KMO (0.55) KMOPARP1CES2CES1KDM4E
SCHEMBL7405902 0.82 KMO (0.55) KMOPARP1CES2CES1KDM4E
SCHEMBL3673838 0.82 KMO (0.55) KMOPARP1CES2CES1KDM4E
SCHEMBL7799557 0.81 TSHR (0.64) KMOCES1KDM4EHIF1ATDP1
SCHEMBL2791083 0.81 TSHR (0.64) KMOCES1KDM4EHIF1ATDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES VARASI MARIO (IT) 2001-07-19 US disclosed
EP-0662948-B1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES WITH KYNURENINASE AND/OR KYNURENINE-3-HYDROXYLASE INHIBITING ACTIVITY PHARMACIA & UPJOHN SPA (IT) 1998-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010008947-A1 2-AMINO-4-PHENYL-4-OXO-BUTYRIC ACID DERIVATIVES KYNU, KMO, ABAT KMO 2/4885PARP1 2682/4885CES2 1385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.